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Clinics and pathology 
Disease 
Treatment related leukemia (treatment related acute 
myeloid leukemia, t-AML) 
Epidemiology 
The involvement of MLL in 11q23 and KIAA0284 in 
14q32 was shown in only 2 cases (Burmeister et al., 
2008; De Braekeleer et al., 2009). These 2 cases were
treatment related leukemia cases (t-AML for: treatment 
related acute myeloid leukemia). These t-AML cases 
occurred in a 45-year-old male patient (a M1 case) nd 
in a 65-year-old female patient, 2 years after an 
urothelial carcinoma and 5 years after a ductal 
mammary carcinoma respectively. In 1 other case of 
t(11;14)(q23;q32), a myelodysplastic syndrome case, 
the involvement of MLL was excluded, and IGH in 
14q32 was rearranged (Yujiri et al., 2009). Finally, in 2 
other cases of t(11;14)(q23;q32), no molecular studies 
were available (Kaneko et al., 1982; Hanson et al., 
1993). The two latter cases were a biphenotypic 
leukemia (BAL) case and an acute lymphoblastic 
leukemia (ALL) in a 33-year-old male patient. 
Prognosis 
One of the t-AML cases died 2 months after diagnosis, 
while the other one was lost to follow-up 5 years after 




The t(11;14)(q23;q32) was the sole anomaly in the 2 
cases were MLL and KIAA0284 involvements  
were ascertained. The BAL case showed a complex 
karyotype with -7 and i(17q), the ALL case also had a 
complex karyotype, with +12. 





36 exons, multiple transcripts 13-15 kb. 
Protein 
3969 amino acids; 431 kDa; contains two DNA binding 
motifs (a AT hook and a CXXC domain), a DNA 
methyl transferase motif, a bromodomain. MLL is 
cleaved by taspase 1 into 2 proteins before entering the 
nucleus, called MLL-N and MLL-C. The FYRN and a 
FRYC domains of native MLL associate MLL-N and 
MLL-C in a stable complex; they form a multiprotein 
complex with transcription factor TFIID. MLL is a 
transcriptional regulatory factor. MLL can be 
associated with more than 30 proteins, including the 
core components of the SWI/SNF chromatin 
remodeling complex and the transcription complex 
TFIID. MLL binds promotors of HOX genes through 
acetylation and methylation of histones. MLL is a 






KIAA0284 presents an amino acids similarity of  
30% with CEP170. CEP170 is a forkhead-associated  
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domain protein which associates with centrosomes 
during interphase and with spindle microtubules during 
mitosis (Guarguaglini et al., 2005). 




5' MLL - 3' KIAA0284 
Transcript 
The breakpoint was located in intron 9 of MLL. The 
breakpoint in KIAA0284 was located in intron 2 in oe 
case, and intron 4 in the other case. 
Fusion protein 
Description 
N-term MLL - C-term KIAA0284 
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